Access the full text.
Sign up today, get DeepDyve free for 14 days.
Zhi-min Long, Lei Zhao, R. Jiang, Kejian Wang, Shi-fang Luo, Min Zheng, Xiao-Feng Li, Gui-Qiong He (2015)
Valproic Acid Modifies Synaptic Structure and Accelerates Neurite Outgrowth Via the Glycogen Synthase Kinase‐3β Signaling Pathway in an Alzheimer's Disease ModelCNS Neuroscience & Therapeutics, 21
Haifa Shen, Tong Sun, Mauro Ferrari (2012)
Nanovector delivery of siRNA for cancer therapyCancer Gene Therapy, 19
D. Irwin, M. Grossman, D. Weintraub, H. Hurtig, J. Duda, S. Xie, Eddie Lee, V. Deerlin, O. Lopez, J. Kofler, P. Nelson, G. Jicha, R. Woltjer, J. Quinn, J. Quinn, J. Kaye, J. Leverenz, J. Leverenz, D. Tsuang, Katelan Longfellow, D. Yearout, W. Kukull, C. Keene, T. Montine, T. Montine, C. Zabetian, J. Trojanowski (2017)
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysisThe Lancet Neurology, 16
Sarah Kaufman, David Sanders, Talitha Thomas, Allison Ruchinskas, Jaime Vaquer‐Alicea, Apurwa Sharma, T. Miller, M. Diamond (2016)
Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In VivoNeuron, 92
Z. Ahmed, E. Bigio, H. Budka, D. Dickson, I. Ferrer, B. Ghetti, G. Giaccone, K. Hatanpaa, J. Holton, K. Josephs, J. Powers, S. Spina, H. Takahashi, C. White, T. Révész, G. Kovacs (2013)
Globular glial tauopathies (GGT): consensus recommendationsActa Neuropathologica, 126
G. Bensimon, A. Ludolph, Y. Agid, M. Vidailhet, C. Payan, P. Leigh (2008)
Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS StudyBrain, 132
H. Rosenmann, N. Grigoriadis, D. Karussis, M. Boimel, O. Touloumi, H. Ovadia, O. Abramsky (2006)
Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein.Archives of neurology, 63 10
J. Crary, J. Trojanowski, J. Schneider, J. Abisambra, E. Abner, I. Alafuzoff, S. Arnold, J. Attems, T. Beach, E. Bigio, N. Cairns, D. Dickson, M. Gearing, L. Grinberg, P. Hof, B. Hyman, K. Jellinger, G. Jicha, G. Kovacs, D. Knopman, J. Kofler, W. Kukull, I. Mackenzie, E. Masliah, A. Mckee, T. Montine, M. Murray, J. Neltner, I. Santa-María, W. Seeley, A. Serrano‐Pozo, M. Shelanski, T. Stein, M. Takao, D. Thal, J. Toledo, J. Troncoso, J. Vonsattel, C. White, T. Wisniewski, R. Woltjer, M. Yamada, P. Nelson (2014)
Primary age-related tauopathy (PART): a common pathology associated with human agingActa Neuropathologica, 128
Nicolas Barthélemy, A. Gabelle, C. Hirtz, F. Fenaille, N. Sergeant, S. Schraen-Maschke, J. Vialaret, L. Buée, C. Junot, F. Becher, S. Lehmann (2016)
Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.Journal of Alzheimer's disease : JAD, 51 4
D. Irwin, V. Lee, J. Trojanowski (2013)
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologiesNature Reviews Neuroscience, 14
H. Ouden, N. Daw, Guillén Fernández, J. Elshout, M. Rijpkema, M. Hoogman, Barbara Franke, R. Cools (2013)
Dissociable Effects of Dopamine and Serotonin on Reversal LearningNeuron, 80
T. Ahmed, A. Jeugd, D. Blum, M. Galas, R. D'Hooge, L. Buée, D. Balschun (2014)
Cognition and hippocampal synaptic plasticity in mice with a homozygous tau deletionNeurobiology of Aging, 35
Udi Vazana, R. Veksler, G. Pell, O. Prager, Michael Fassler, Yoash Chassidim, Y. Roth, H. Shahar, A. Zangen, R. Raccah, E. Onesti, M. Ceccanti, C. Colonnese, A. Santoro, M. Salvati, A. D'Elia, V. Nucciarelli, Maurizio Inghilleri, A. Friedman (2016)
Glutamate-Mediated Blood–Brain Barrier Opening: Implications for Neuroprotection and Drug DeliveryThe Journal of Neuroscience, 36
C. McMillan, D. Irwin, I. Nasrallah, J. Phillips, Meredith Spindler, K. Rascovsky, Kylie Ternes, Charles Jester, D. Wolk, L. Kwong, V. Lee, Eddie Lee, J. Trojanowski, M. Grossman (2016)
Multimodal evaluation demonstrates in vivo 18F-AV-1451 uptake in autopsy-confirmed corticobasal degenerationActa Neuropathologica, 132
A. Hughes, S. Daniel, Y. Ben-Shlomo, A. Lees (2002)
The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service.Brain : a journal of neurology, 125 Pt 4
K. Nieforth, L. Golbe (1993)
Retrospective study of drug response in 87 patients with progressive supranuclear palsy.Clinical neuropharmacology, 16 4
H. Kordasiewicz, L. Stanek, E. Wancewicz, C. Mazur, Melissa McAlonis, Kimberly A. Pytel, Jonathan Artates, A. Weiss, Seng Cheng, L. Shihabuddin, G. Hung, C. Bennett, D. Cleveland (2012)
Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin SynthesisNeuron, 74
D. Apetauerova, S. Scala, R. Hamill, D. Simon, Subash Pathak, R. Ruthazer, D. Standaert, T. Yacoubian (2016)
CoQ10 in progressive supranuclear palsyNeurology® Neuroimmunology & Neuroinflammation, 3
G. Respondek, M. Stamelou, C. Kurz, L. Ferguson, A. Rajput, W. Chiu, J. Swieten, C. Troakes, Safa Sarraj, E. Gelpí, C. Gaig, E. Tolosa, W. Oertel, A. Giese, S. Roeber, T. Arzberger, S. Wagenpfeil, G. Höglinger (2014)
The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite casesMovement Disorders, 29
C. Raoul, T. Abbas-Terki, J. Bensadoun, Sandrine Guillot, G. Haase, J. Szulc, C. Henderson, P. Aebischer (2005)
Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALSNature Medicine, 11
I. Litvan, Y. Agid, C. Goetz, J. Jankovic, G. Wenning, J. Brandel, E. Lai, M. Verny, K. Ray-Chaudhuri, A. Mckee, K. Jellinger, R. Pearce, J. Bartko (1997)
Accuracy of the Clinical Diagnosis of Corticobasal DegenerationNeurology, 48
A. Ittner, Josefine Bertz, Lisa Suh, C. Stevens, J. Götz, L. Ittner (2015)
Tau‐targeting passive immunization modulates aspects of pathology in tau transgenic miceJournal of Neurochemistry, 132
C. Wischik, P. Edwards, Robert Lai, M. Roth, C. Harrington (1996)
Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines.Proceedings of the National Academy of Sciences of the United States of America, 93 20
V. Bachanova, L. Burns, K. Ahn, G. Laport, G. Akpek, M. Kharfan-Dabaja, T. Nishihori, E. Agura, P. Armand, S. Jaglowski, M. Cairo, A. Cashen, Jonathon Cohen, A. D’Souza, C. Freytes, R. Gale, S. Ganguly, N. Ghosh, L. Holmberg, D. Inwards, A. Kanate, H. Lazarus, Adriana Malone, R. Munker, A. Mussetti, M. Norkin, T. Prestidge, J. Rowe, P. Satwani, T. Siddiqi, P. Stiff, B. William, B. Wirk, D. Maloney, Sonali Smith, A. Sureda, J. Carreras, M. Hamadani (2015)
Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 21 9
Isidro Ferrer, E. Pozas, E. López, J. Ballabriga (1997)
Bcl-2, Bax and Bcl-x expression following hypoxia-ischemia in the infant rat brainActa Neuropathologica, 94
J. Rohrer, Jennifer Nicholas, D. Cash, J. Swieten, E. Dopper, L. Jiskoot, R. Minkelen, S. Rombouts, M. Cardoso, S. Clegg, Miklós Espák, S. Mead, D. Thomas, E. Vita, M. Masellis, S. Black, M. Freedman, R. Keren, B. MacIntosh, E. Rogaeva, D. Tang‐Wai, M. Tartaglia, R. Laforce, F. Tagliavini, P. Tiraboschi, V. Redaelli, S. Prioni, M. Grisoli, B. Borroni, A. Padovani, D. Galimberti, E. Scarpini, A. Arighi, G. Fumagalli, J. Rowe, I. Coyle-Gilchrist, C. Graff, M. Fallström, V. Jelic, A. Ståhlbom, Christin Andersson, H. Thonberg, L. Lilius, G. Frisoni, G. Binetti, M. Pievani, M. Bocchetta, L. Benussi, R. Ghidoni, E. Finger, S. Sorbi, B. Nacmias, G. Lombardi, C. Polito, J. Warren, S. Ourselin, Nick Fox, M. Rossor (2015)
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysisThe Lancet Neurology, 14
D. Irwin, T. Cohen, M. Grossman, S. Arnold, S. Xie, V. Lee, J. Trojanowski (2012)
Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.Brain : a journal of neurology, 135 Pt 3
J. Kreuter (2002)
Transport of Drugs Across the Blood-Brain Barrier by NanoparticlesCurrent Medicinal Chemistry - Central Nervous System Agents, 2
G. Fabbrini, P. Barbanti, V. Bonifati, C. Colosimo, M. Gasparini, N. Vanacore, G. Meco (2001)
Donepezil in the treatment of progressive supranuclear palsyActa Neurologica Scandinavica, 103
E. Sigurdsson (2015)
Tau ImmunotherapyNeurodegenerative Diseases, 16
A. Asuni, A. Boutajangout, D. Quartermain, E. Sigurdsson (2007)
Immunotherapy Targeting Pathological Tau Conformers in a Tangle Mouse Model Reduces Brain Pathology with Associated Functional ImprovementsThe Journal of Neuroscience, 27
D. Dickson, Z. Ahmed, A. Algom, Y. Tsuboi, K. Josephs (2010)
Neuropathology of variants of progressive supranuclear palsy.Current opinion in neurology, 23 4
Nicholas Franich, H. Fitzsimons, Dahna Fong, M. Klugmann, M. During, D. Young (2008)
AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease.Molecular therapy : the journal of the American Society of Gene Therapy, 16 5
Lea Rozenstein-Tsalkovich, N. Grigoriadis, A. Lourbopoulos, Evangelia Nousiopoulou, I. Kassis, O. Abramsky, D. Karussis, H. Rosenmann (2013)
Repeated immunization of mice with phosphorylated-tau peptides causes neuroinflammationExperimental Neurology, 248
L. Ittner, Y. Ke, F. Delerue, Mian Bi, Amadeus Gladbach, Janet Eersel, Heidrun Wölfing, B. Chieng, M. Christie, I. Napier, A. Eckert, M. Staufenbiel, Edna Hardeman, J. Götz (2010)
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse ModelsCell, 142
H. Braak, E. Braak (2004)
Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 82
T. Cohen, Jing Guo, David Hurtado, L. Kwong, Ian Mills, J. Trojanowski, V. Lee (2011)
The acetylation of tau inhibits its function and promotes pathological tau aggregation.Nature communications, 2
G. Höglinger, H. Huppertz, S. Wagenpfeil, M. Andrés, V. Belloch, T. León, T. Ser (2014)
Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trialMovement Disorders, 29
K. Leroy, K. Ando, V. Laporte, R. Dedecker, V. Suain, M. Authelet, Céline Héraud, Nathalie Pierrot, Z. Yılmaz, J. Octave, J. Brion (2012)
Lack of tau proteins rescues neuronal cell death and decreases amyloidogenic processing of APP in APP/PS1 mice.The American journal of pathology, 181 6
S. Sankaranarayanan, D. Barten, L. Vana, N. Devidze, Ling Yang, G. Cadelina, N. Hoque, L. Decarr, S. Keenan, Alan Lin, Yang Cao, B. Snyder, Bin Zhang, Magdalena Nitla, Gregg Hirschfeld, N. Barrezueta, C. Polson, P. Wes, V. Rangan, A. Cacace, C. Albright, J. Meredith, J. Trojanowski, V. Lee, K. Brunden, M. Ahlijanian (2015)
Passive Immunization with Phospho-Tau Antibodies Reduces Tau Pathology and Functional Deficits in Two Distinct Mouse Tauopathy ModelsPLoS ONE, 10
A. Quattrone, G. Nicoletti, D. Messina, F. Fera, F. Condino, P. Pugliese, P. Lanza, P. Barone, L. Morgante, M. Zappia, U. Aguglia, O. Gallo (2008)
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.Radiology, 246 1
Grisel Lopez, K. Bayulkem, Mark Hallett (2016)
Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variantsActa Neurologica Scandinavica, 134
G. Höglinger, G. Respondek, M. Stamelou, C. Kurz, K. Josephs, A. Lang, B. Mollenhauer, U. Müller, C. Nilsson, J. Whitwell, T. Arzberger, E. Englund, E. Gelpí, A. Giese, D. Irwin, W. Meissner, A. Pantelyat, A. Rajput, J. Swieten, C. Troakes, A. Antonini, K. Bhatia, Y. Bordelon, Y. Compta, J. Corvol, C. Colosimo, D. Dickson, R. Dodel, L. Ferguson, M. Grossman, J. Kassubek, F. Krismer, J. Levin, S. Lorenzl, H. Morris, P. Nestor, W. Oertel, W. Poewe, G. Rabinovici, J. Rowe, G. Schellenberg, K. Seppi, T. Eimeren, G. Wenning, A. Boxer, L. Golbe, I. Litvan (2017)
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaMovement Disorders, 32
D. Piedrahita, I. Hernandez, Alejandro López-Tobón, D. Fedorov, B. Obara, B. Manjunath, Ryan Boudreau, B. Davidson, F. LaFerla, J. Gallego-Gómez, K. Kosik, G. Cardona-Gómez (2010)
Silencing of CDK5 Reduces Neurofibrillary Tangles in Transgenic Alzheimer's MiceThe Journal of Neuroscience, 30
Salvatore Nigro, G. Arabia, A. Antonini, Luca Weis, A. Marcante, A. Tessitore, M. Cirillo, G. Tedeschi, S. Zanigni, G. Calandra-Buonaura, C. Tonon, G. Pezzoli, R. Cilia, M. Zappia, A. Nicoletti, C. Cicero, M. Tinazzi, P. Tocco, N. Cardobi, A. Quattrone (2017)
Magnetic Resonance Parkinsonism Index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsyEuropean Radiology, 27
L. Passamonti, Patricia Rodríguez, Young Hong, K. Allinson, D. Williamson, R. Borchert, S. Sami, T. Cope, W. Bevan-Jones, P. Jones, R. Arnold, A. Surendranathan, E. Mak, L. Su, T. Fryer, F. Aigbirhio, J. O'Brien, J. Rowe (2017)
18F-AV-1451 positron emission tomography in Alzheimer’s disease and progressive supranuclear palsyBrain, 140
L. Binder, Angela Guillozet-Bongaarts, F. García-Sierra, R. Berry (2005)
Tau, tangles, and Alzheimer's disease.Biochimica et biophysica acta, 1739 2-3
A. Boxer, A. Lang, M. Grossman, D. Knopman, B. Miller, L. Schneider, R. Doody, A. Lees, L. Golbe, David Williams, J. Corvol, A. Ludolph, D. Burn, S. Lorenzl, I. Litvan, E. Roberson, G. Höglinger, M. Koestler, C. Jack, Viviana Deerlin, C. Randolph, I. Lobach, H. Heuer, I. Gozes, L. Parker, S. Whitaker, J. Hirman, Alistair Stewart, M. Gold, Bruce Morimoto (2014)
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trialThe Lancet Neurology, 13
Najla Kfoury, Brandon Holmes, Hong Jiang, D. Holtzman, M. Diamond (2012)
Trans-cellular Propagation of Tau Aggregation by Fibrillar Species*The Journal of Biological Chemistry, 287
I. Liepelt, A. Gaenslen, J. Godau, A. Santo, K. Schweitzer, T. Gasser, D. Berg (2010)
Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: Clinical observations as a basis for power calculations and safety analysisAlzheimer's & Dementia, 6
G. Respondek, C. Kurz, T. Arzberger, Y. Compta, E. Englund, L. Ferguson, E. Gelpí, A. Giese, D. Irwin, W. Meissner, C. Nilsson, A. Pantelyat, A. Rajput, J. Swieten, C. Troakes, K. Josephs, A. Lang, B. Mollenhauer, U. Müller, J. Whitwell, A. Antonini, K. Bhatia, Y. Bordelon, J. Corvol, C. Colosimo, R. Dodel, M. Grossman, J. Kassubek, F. Krismer, J. Levin, S. Lorenzl, H. Morris, P. Nestor, W. Oertel, G. Rabinovici, J. Rowe, T. Eimeren, G. Wenning, A. Boxer, L. Golbe, I. Litvan, M. Stamelou, G. Höglinger (2017)
Which ante mortem clinical features predict progressive supranuclear palsy pathology?Movement Disorders, 32
David Sanders, Sarah Kaufman, Sarah DeVos, Apurwa Sharma, Hilda Mirbaha, Aimin Li, Scarlett Barker, Alex Foley, J. Thorpe, L. Serpell, T. Miller, L. Grinberg, W. Seeley, M. Diamond (2014)
Distinct Tau Prion Strains Propagate in Cells and Mice and Define Different TauopathiesNeuron, 82
D. Irwin, Joseph Abrams, L. Schonberger, E. Leschek, J. Mills, V. Lee, J. Trojanowski (2013)
Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone.JAMA neurology, 70 4
G. Kovacs, I. Ferrer, L. Grinberg, I. Alafuzoff, J. Attems, H. Budka, N. Cairns, J. Crary, C. Duyckaerts, B. Ghetti, G. Halliday, J. Ironside, S. Love, I. Mackenzie, D. Munoz, M. Murray, P. Nelson, H. Takahashi, J. Trojanowski, O. Ansorge, T. Arzberger, A. Baborie, T. Beach, Kevin Bieniek, E. Bigio, I. Bodi, B. Dugger, M. Feany, E. Gelpí, S. Gentleman, G. Giaccone, K. Hatanpaa, Richard Heale, P. Hof, M. Hofer, T. Hortobágyi, K. Jellinger, G. Jicha, P. Ince, J. Kofler, E. Kövari, J. Kril, D. Mann, R. Matěj, A. Mckee, C. Mclean, I. Milenkovic, T. Montine, S. Murayama, Eddie Lee, Jasmin Rahimi, R. Rodriguez, A. Rozemüller, J. Schneider, C. Schultz, W. Seeley, D. Seilhean, Colin Smith, F. Tagliavini, M. Takao, D. Thal, J. Toledo, M. Tolnay, J. Troncoso, H. Vinters, S. Weis, S. Wharton, C. White, T. Wisniewski, J. Woulfe, M. Yamada, D. Dickson (2015)
Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategyActa Neuropathologica, 131
Jing Guo, Virginia Lee (2013)
Neurofibrillary tangle‐like tau pathology induced by synthetic tau fibrils in primary neurons over‐expressing mutant tauFEBS Letters, 587
Timothy Miller, A. Pestronk, W. David, J. Rothstein, E. Simpson, Stanley Appel, Patricia Andres, K. Mahoney, P. Allred, K. Alexander, L. Ostrow, D. Schoenfeld, Eric Macklin, Daniel Norris, G. Manousakis, Matthew Crisp, Richard Smith, C Bennett, K. Bishop, M. Cudkowicz (2013)
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man studyThe Lancet Neurology, 12
M. Marquié, M. Normandin, C. Vanderburg, Isabel Costantino, Elizabeth Bien, Lisa Rycyna, W. Klunk, C. Mathis, M. Ikonomovic, M. Debnath, N. Vasdev, B. Dickerson, S. Gomperts, J. Growdon, Keith Johnson, M. Frosch, B. Hyman, T. Gómez-Isla (2015)
Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissueAnnals of Neurology, 78
G. Patrick, L. Zukerberg, M. Nikolic, S. Monte, P. Dikkes, L. Tsai (1999)
Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegenerationNature, 402
D. Cho, Eun Lee, K. Kwon, C. Shin, K. Song, Jung-Hyun Park, I. Jo, Seol-Heui Han (2013)
Troglitazone, a thiazolidinedione, decreases tau phosphorylation through the inhibition of cyclin‐dependent kinase 5 activity in SH‐SY5Y neuroblastoma cells and primary neuronsJournal of Neurochemistry, 126
Brian Mead, Namho Kim, G. Miller, David Hodges, P. Mastorakos, A. Klibanov, J. Mandell, J. Hirsh, J. Suk, J. Hanes, R. Price (2017)
Novel Focused Ultrasound Gene Therapy Approach Noninvasively Restores Dopaminergic Neuron Function in a Rat Parkinson's Disease Model.Nano letters, 17 6
M. Gorno-Tempini, M. Gorno-Tempini, A. Hillis, S. Weintraub, A. Kertesz, Mario Mendez, S. Cappa, J. Ogar, J. Rohrer, S. Black, B. Boeve, F. Manes, N. Dronkers, Rik Vandenberghe, K. Rascovsky, K. Patterson, B. Miller, D. Knopman, J. Hodges, M. Mesulam, M. Grossman (2011)
Classification of primary progressive aphasia and its variantsNeurology, 76
S. Lovestone, M. Boada, B. Dubois, M. Hüll, J. Rinne, H. Huppertz, M. Calero, M. Andrés, Belén Gómez-Carrillo, T. León, T. Ser (2015)
A phase II trial of tideglusib in Alzheimer's disease.Journal of Alzheimer's disease : JAD, 45 1
S. Boluda, M. Iba, Bin Zhang, Kevin Raible, V. Lee, J. Trojanowski (2015)
Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer’s disease or corticobasal degeneration brainsActa Neuropathologica, 129
S. Yuzwa, X. Shan, Matthew Macauley, Thomas Clark, Y. Skorobogatko, K. Vosseller, D. Vocadlo (2012)
Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation.Nature chemical biology, 8 4
Keith Johnson, A. Schultz, R. Betensky, J. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, Jonathan Alverio, Kelly Judge, Marlie Philiossaint, T. Shoup, Daniel Yokell, B. Dickerson, T. Gómez-Isla, B. Hyman, N. Vasdev, R. Sperling (2016)
Tau positron emission tomographic imaging in aging and early Alzheimer diseaseAnnals of Neurology, 79
Suzee Lee, G. Rabinovici, M. Mayo, Stephen Wilson, W. Seeley, S. DeArmond, Eric Huang, J. Trojanowski, M. Growdon, J. Jang, M. Sidhu, Tricia See, A. Karydas, M. Gorno-Tempini, A. Boxer, M. Weiner, M. Geschwind, K. Rankin, B. Miller (2011)
Clinicopathological correlations in corticobasal degenerationAnnals of Neurology, 70
M. Boimel, N. Grigoriadis, A. Lourbopoulos, Esther Haber, O. Abramsky, H. Rosenmann (2010)
Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in miceExperimental Neurology, 224
J. Pedersen, E. Sigurdsson (2015)
Tau immunotherapy for Alzheimer's disease.Trends in molecular medicine, 21 6
K. Rascovsky, J. Hodges, D. Knopman, M. Mendez, J. Kramer, J. Neuhaus, J. Swieten, H. Seelaar, E. Dopper, C. Onyike, A. Hillis, K. Josephs, B. Boeve, A. Kertesz, W. Seeley, K. Rankin, Julene Johnson, M. Gorno-Tempini, H. Rosen, Caroline Prioleau-Latham, Albert Lee, C. Kipps, P. Lillo, O. Piguet, J. Rohrer, M. Rossor, J. Warren, Nick Fox, D. Galasko, D. Salmon, S. Black, M. Mesulam, S. Weintraub, B. Dickerson, J. Diehl-Schmid, F. Pasquier, V. Deramecourt, F. Lebert, Y. Pijnenburg, T. Chow, F. Manes, J. Grafman, S. Cappa, M. Freedman, M. Grossman, B. Miller (2011)
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.Brain : a journal of neurology, 134 Pt 9
K. Yanamandra, Hong Jiang, Thomas Mahan, S. Maloney, D. Wozniak, M. Diamond, D. Holtzman (2015)
Anti-tau antibody reduces insoluble tau and decreases brain atrophyAnnals of Clinical and Translational Neurology, 2
M. Grossman, L. Elman, L. McCluskey, C. McMillan, A. Boller, John Powers, K. Rascovsky, William Hu, L. Shaw, D. Irwin, V. Lee, J. Trojanowski (2014)
Phosphorylated tau as a candidate biomarker for amyotrophic lateral sclerosis.JAMA neurology, 71 4
E. Kontseková, N. Zilka, B. Kovacech, P. Novak, M. Novák (2014)
First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease modelAlzheimer's Research & Therapy, 6
G. Respondek, S. Roeber, H. Kretzschmar, C. Troakes, S. Al-Sarraj, E. Gelpí, C. Gaig, W. Chiu, J. Swieten, W. Oertel, G. Höglinger (2013)
Accuracy of the national institute for neurological disorders and stroke/society for progressive supranuclear palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsyMovement Disorders, 28
David Chien, A. Szardenings, S. Bahri, J. Walsh, Fanrong Mu, Chunfang Xia, W. Shankle, A. Lerner, M. Su, Arkadij Elizarov, H. Kolb (2014)
Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808.Journal of Alzheimer's disease : JAD, 38 1
M. Geschwind, A. Haman, B. Miller (2007)
Rapidly progressive dementia.Neurologic clinics, 25 3
S. Zanigni, G. Calandra-Buonaura, D. Manners, C. Testa, D. Gibertoni, S. Evangelisti, L. Sambati, M. Guarino, P. Massis, L. Gramegna, C. Bianchini, P. Rucci, P. Cortelli, R. Lodi, C. Tonon (2016)
Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's diseaseNeuroImage : Clinical, 11
H. Hampel, M. Ewers, K. Bürger, P. Annas, A. Mörtberg, A. Bogstedt, L. Frölich, J. Schröder, P. Schönknecht, M. Riepe, I. Kraft, T. Gasser, T. Leyhe, H. Möller, A. Kurz, H. Basun (2009)
Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.The Journal of clinical psychiatry, 70 6
I. Litvan, Y. Agid, D. Calne, G. Campbell, B. Dubois, R. Duvoisin, C. Goetz, L. Golbe, J. Grafman, J. Growdon, M. Hallett, J. Jankovic, N. Quinn, E. Tolosa, D. Zee (1996)
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)Neurology, 47
K. Brunden, N. Gardner, Michael James, Yuemang Yao, J. Trojanowski, V. Lee, I. Paterson, C. Ballatore, Amos Smith (2013)
MT-Stabilizer, Dictyostatin, Exhibits Prolonged Brain Retention and Activity: Potential Therapeutic Implications.ACS medicinal chemistry letters, 4 9
A. Hussl, P. Mahlknecht, C. Scherfler, R. Esterhammer, M. Schocke, W. Poewe, K. Seppi (2010)
Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain‐to‐pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophyMovement Disorders, 25
T. Arai, M. Hasegawa, Takashi Nonoka, F. Kametani, M. Yamashita, M. Hosokawa, K. Niizato, K. Tsuchiya, Z. Kobayashi, K. Ikeda, Mari Yoshida, M. Onaya, H. Fujishiro, H. Akiyama (2010)
Phosphorylated and cleaved TDP‐43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP‐43 proteinopathyNeuropathology, 30
B. Borroni, M. Malinverno, F. Gardoni, A. Alberici, L. Parnetti, E. Premi, U. Bonuccelli, M. Grassi, D. Perani, P. Calabresi, M. Luca, A. Padovani (2008)
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsyNeurology, 71
A. Boutajangout, Jóhanna Ingadóttir, P. Davies, E. Sigurdsson (2011)
Passive immunization targeting pathological phospho‐tau protein in a mouse model reduces functional decline and clears tau aggregates from the brainJournal of Neurochemistry, 118
Ruben Smith, M. Schain, C. Nilsson, O. Strandberg, Tomas Olsson, Douglas Hägerström, Jonas Jögi, E. Borroni, M. Schöll, M. Honer, O. Hansson (2016)
Increased basal ganglia binding of 18 F‐AV‐1451 in patients with progressive supranuclear palsyMovement Disorders, 32
L. Massey, H. Jäger, D. Paviour, S. O'sullivan, H. Ling, David Williams, C. Kallis, J. Holton, T. Révész, D. Burn, T. Yousry, A. Lees, N. Fox, C. Micallef (2013)
The midbrain to pons ratioNeurology, 80
H. Dawson, Adriana Ferreira, Michele Eyster, N. Ghoshal, L. Binder, M. Vitek (2001)
Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice.Journal of cell science, 114 Pt 6
P. Novak, R. Schmidt, E. Kontseková, N. Zilka, B. Kovacech, R. Škrabana, Zuzana Vince-Kazmerova, S. Katina, L. Fialova, M. Prčina, V. Parrák, P. Dal-Bianco, M. Brunner, W. Staffen, M. Rainer, M. Ondrus, S. Ropele, M. Smisek, Roman Sivak, B. Winblad, M. Novák (2017)
Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trialThe Lancet Neurology, 16
I. Litvan, M. Phipps, V. Pharr, M. Hallett, J. Grafman, A. Salazar (2001)
Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsyNeurology, 57
Meaghan Morris, Patricia Hamto, A. Adame, N. Devidze, E. Masliah, L. Mucke (2013)
Age-appropriate cognition and subtle dopamine-independent motor deficits in aged Tau knockout miceNeurobiology of Aging, 34
Mian Bi, A. Ittner, Y. Ke, J. Götz, L. Ittner (2011)
Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic MicePLoS ONE, 6
E. Roberson, Brian Halabisky, Jong Yoo, J. Yao, J. Chin, F. Yan, Tiffany Wu, Patricia Hamto, N. Devidze, Gui-qiu Yu, J. Palop, J. Noebels, L. Mucke (2011)
Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's DiseaseThe Journal of Neuroscience, 31
Bin Zhang, A. Maiti, S. Shively, Fara Lakhani, G. Mcdonald-Jones, J. Bruce, Eddie Lee, S. Xie, S. Joyce, Chi Li, P. Toleikis, V. Lee, J. Trojanowski (2005)
Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model.Proceedings of the National Academy of Sciences of the United States of America, 102 1
M. Adachi, T. Kawanami, H. Ohshima, Y. Sugai, T. Hosoya (2004)
Morning glory sign: a particular MR finding in progressive supranuclear palsy.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine, 3 3
Tereza Alecou, M. Giannakou, C. Damianou (2017)
Amyloid β Plaque Reduction With Antibodies Crossing the Blood‐Brain Barrier, Which Was Opened in 3 Sessions of Focused Ultrasound in a Rabbit ModelJournal of Ultrasound in Medicine, 36
E. Roberson, K. Scearce-Levie, J. Palop, F. Yan, I. Cheng, Tiffany Wu, H. Gerstein, Gui-qiu Yu, L. Mucke (2007)
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse ModelScience, 316
I. Santa-María, M. Alaniz, N. Renwick, C. Cela, T. Fulga, D. Vactor, T. Tuschl, L. Clark, M. Shelanski, B. McCabe, John Crary (2015)
Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau.The Journal of clinical investigation, 125 2
P. Nelson, I. Alafuzoff, E. Bigio, C. Bouras, H. Braak, N. Cairns, Rudolph Castellani, B. Crain, P. Davies, K. Tredici, C. Duyckaerts, M. Frosch, V. Haroutunian, P. Hof, C. Hulette, B. Hyman, T. Iwatsubo, K. Jellinger, G. Jicha, E. Kövari, W. Kukull, J. Leverenz, S. Love, I. Mackenzie, D. Mann, E. Masliah, A. Mckee, T. Montine, J. Morris, J. Schneider, J. Sonnen, D. Thal, J. Trojanowski, J. Troncoso, T. Wisniewski, R. Woltjer, T. Beach (2012)
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the LiteratureJournal of Neuropathology & Experimental Neurology, 71
Hanna Cho, J. Choi, Mi Hwang, Seung Lee, Y. Ryu, M. Lee, C. Lyoo (2017)
Subcortical 18F‐AV‐1451 binding patterns in progressive supranuclear palsyMovement Disorders, 32
M. Iba, Jing Guo, Jennifer McBride, Bin Zhang, J. Trojanowski, V. Lee (2013)
Synthetic Tau Fibrils Mediate Transmission of Neurofibrillary Tangles in a Transgenic Mouse Model of Alzheimer's-Like TauopathyThe Journal of Neuroscience, 33
I. Ceccarelli, Pasquale Fiengo, Rosaria Remelli, V. Miragliotta, Lara Rossini, I. Biotti, A. Cappelli, Lara Petricca, S. Rosa, A. Caricasole, G. Pollio, C. Scali (2016)
Recombinant Adeno Associated Viral (AAV) vector type 9 delivery of Ex1-Q138-mutant huntingtin in the rat striatum as a short-time model for in vivo studies in drug discoveryNeurobiology of Disease, 86
M. Goedert, R. Jakes (1990)
Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization.The EMBO Journal, 9
I. Ferrer, M. Barrachina, B. Puig (2002)
Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degenerationActa Neuropathologica, 104
Xihui Gao, Jun Qian, Shuyan Zheng, Yinzhi Changyi, Jianping Zhang, S. Ju, Jianhua Zhu, Cong Li (2014)
Overcoming the blood-brain barrier for delivering drugs into the brain by using adenosine receptor nanoagonist.ACS nano, 8 4
A. Boxer, M. Gold, E. Huey, William Hu, Howard Rosen, J. Kramer, F. Gao, E. Burton, T. Chow, A. Kao, B. Leavitt, B. Lamb, M. Grether, D. Knopman, N. Cairns, I. Mackenzie, L. Mitic, E. Roberson, D. Kammen, M. Cantillon, K. Zahs, George Jackson, S. Salloway, J. Morris, G. Tong, H. Feldman, H. Fillit, S. Dickinson, Z. Khachaturian, Margaret Sutherland, S. Abushakra, Joseph Lewcock, Robert Farese, R. Kenet, F. LaFerla, S. Perrin, S. Whitaker, Lawrence Honig, M. Mesulam, B. Boeve, M. Grossman, B. Miller, J. Cummings (2013)
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier)Alzheimer's & Dementia, 9
M. Schmidt, T. Schuck, S. Sheridan, M. Kung, H. Kung, Z. Zhuang, C. Bergeron, J. Lamarche, D. Skovronsky, B. Giasson, V. Lee, J. Trojanowski (2001)
The fluorescent Congo red derivative, (trans, trans)-1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (BSB), labels diverse beta-pleated sheet structures in postmortem human neurodegenerative disease brains.The American journal of pathology, 159 3
Kathleen Polo, B. Jabbari (1994)
Botulinum toxin‐A improves the rigidity of progressive supranuclear palsyAnnals of Neurology, 35
J. Whitwell, K. Josephs (2012)
Neuroimaging in frontotemporal lobar degeneration—predicting molecular pathologyNature Reviews Neurology, 8
I. Ferrer, G. Santpere, F. Leeuwen (2008)
Argyrophilic grain disease.Brain : a journal of neurology, 131 Pt 6
Hong Xu, T. Rösler, T. Carlsson, A. Andrade, O. Fiala, Matthias Hollerhage, W. Oertel, M. Goedert, A. Aigner, G. Höglinger (2014)
Tau silencing by siRNA in the P301S mouse model of tauopathy.Current gene therapy, 14 5
M. Stamelou, A. Reuss, U. Pilatus, J. Magerkurth, P. Niklowitz, K. Eggert, A. Krisp, T. Menke, C. Schade-Brittinger, W. Oertel, G. Höglinger (2008)
Short‐term effects of coenzyme Q10 in progressive supranuclear palsy: A randomized, placebo‐controlled trialMovement Disorders, 23
D. Castillo-Carranza, J. Gerson, U. Sengupta, M. Guerrero-Munoz, C. Lasagna-Reeves, R. Kayed (2014)
Specific targeting of tau oligomers in Htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seeds.Journal of Alzheimer's disease : JAD, 40 Suppl 1
M. Wolfe (2012)
The Role of Tau in Neurodegenerative Diseases and Its Potential as a Therapeutic TargetScientifica, 2012
William Hu, Kelly Watts, M. Grossman, J. Glass, J. Lah, Chadwick Hales, Matthew Shelnutt, V. Deerlin, J. Trojanowski, A. Levey (2013)
Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDPNeurology, 81
C. Theunis, N. Crespo-Biel, V. Gafner, M. Pihlgren, M. López-Deber, P. Reis, D. Hickman, O. Adolfsson, N. Chuard, Dorin Ndao, P. Borghgraef, H. Devijver, F. Leuven, A. Pfeifer, A. Muhs (2013)
Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model TauopathyPLoS ONE, 8
Richard Finkel, Claudia Chiriboga, J. Vajsar, J. Day, J. Montes, D. Vivo, M. Yamashita, F. Rigo, G. Hung, E. Schneider, Daniel Norris, S. Xia, C. Bennett, K. Bishop (2016)
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation studyThe Lancet, 388
D. Bolton, M. McKinley, S. Prusiner (1982)
Identification of a protein that purifies with the scrapie prion.Science, 218 4579
I. Mackenzie, M. Neumann, E. Bigio, N. Cairns, I. Alafuzoff, J. Kril, G. Kovacs, B. Ghetti, G. Halliday, I. Holm, P. Ince, W. Kamphorst, T. Révész, A. Rozemuller, S. Kumar-Singh, H. Akiyama, A. Baborie, S. Spina, D. Dickson, J. Trojanowski, D. Mann (2009)
Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an updateActa Neuropathologica, 119
N. Kato, K. Arai, T. Hattori (2003)
Study of the rostral midbrain atrophy in progressive supranuclear palsyJournal of the Neurological Sciences, 210
D. Irwin, J. Brettschneider, C. McMillan, Felicia Cooper, C. Olm, S. Arnold, V. Deerlin, W. Seeley, B. Miller, Eddie Lee, V. Lee, M. Grossman, J. Trojanowski (2016)
Deep clinical and neuropathological phenotyping of Pick diseaseAnnals of Neurology, 79
A. Crowe, Michael James, V. Lee, Amos Smith, J. Trojanowski, C. Ballatore, K. Brunden (2013)
Aminothienopyridazines and Methylene Blue Affect Tau Fibrillization via Cysteine Oxidation*The Journal of Biological Chemistry, 288
V. Lee, B. Balin, L. Otvos, J. Trojanowski (1991)
A68: a major subunit of paired helical filaments and derivatized forms of normal Tau.Science, 251 4994
M. Maruyama, H. Shimada, T. Suhara, H. Shinotoh, Bin Ji, J. Maeda, Ming-Rong Zhang, J. Trojanowski, V. Lee, M. Ono, K. Masamoto, H. Takano, N. Sahara, N. Iwata, N. Okamura, S. Furumoto, Y. Kudo, Qing Chang, T. Saido, A. Takashima, Jada Lewis, M. Jang, I. Aoki, Hiroshi Ito, M. Higuchi (2013)
Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal ControlsNeuron, 79
E. Tolosa, I. Litvan, G. Höglinger, D. Burn, A. Lees, M. Andrés, Belén Gómez-Carrillo, T. León, T. Ser (2014)
A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsyMovement Disorders, 29
Hanna Cho, J. Choi, Mi Hwang, Seung Lee, Y. Ryu, M. Lee, C. Lyoo (2016)
Subcortical 18 FAV-1451 Binding Patterns in Progressive Supranuclear Palsy
L. Shaw, H. Vanderstichele, M. Knapik-Czajka, C. Clark, P. Aisen, R. Petersen, K. Blennow, H. Soares, A. Simon, P. Lewczuk, R. Dean, E. Siemers, W. Potter, V. Lee, J. Trojanowski (2009)
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjectsAnnals of Neurology, 65
D. Fitzgerald, D. Emerson, Yongzhen Qian, T. Anwar, D. Liewehr, S. Steinberg, S. Silberman, D. Palmieri, P. Steeg (2012)
TPI-287, a New Taxane Family Member, Reduces the Brain Metastatic Colonization of Breast Cancer CellsMolecular Cancer Therapeutics, 11
C. Duyckaerts, H. Braak, J. Brion, L. Buée, K. Tredici, M. Goedert, G. Halliday, M. Neumann, M. Spillantini, M. Tolnay, T. Uchihara (2015)
PART is part of Alzheimer diseaseActa Neuropathologica, 129
David Chiena, A. Szardeningsa, Shadfar Bahrib, Joseph Walsha, Fanrong Mua, Chunfang Xiaa, William Shanklec, Alan Lernerd, Min-Ying Sub, Arkadij Elizarova, Hartmuth Kolba (2013)
Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807.Journal of Alzheimer's disease : JAD, 34 2
C. Adler, T. Beach, J. Hentz, H. Shill, J. Caviness, Erika Driver-dunckley, M. Sabbagh, L. Sue, S. Jacobson, C. Belden, B. Dugger (2014)
Low clinical diagnostic accuracy of early vs advanced Parkinson diseaseNeurology, 83
Bin Zhang, J. Carroll, J. Trojanowski, Yuemang Yao, M. Iba, J. Potuzak, Anne-Marie Hogan, S. Xie, C. Ballatore, Amos Smith, V. Lee, K. Brunden (2012)
The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic MiceThe Journal of Neuroscience, 32
J. Sundaram, C. Poore, Noor Sulaimee, T. Pareek, A. Asad, R. Rajkumar, W. Cheong, M. Wenk, G. Dawe, K. Chuang, H. Pant, S. Kesavapany (2013)
Specific Inhibition of p25/Cdk5 Activity by the Cdk5 Inhibitory Peptide Reduces Neurodegeneration In VivoThe Journal of Neuroscience, 33
P. Lei, S. Ayton, Steve Moon, Qihao Zhang, I. Volitakis, D. Finkelstein, A. Bush (2014)
Motor and cognitive deficits in aged tau knockout mice in two background strainsMolecular Neurodegeneration, 9
C. McMillan, D. Irwin, B. Avants, John Powers, P. Cook, J. Toledo, Elisabeth Wood, V. Deerlin, V. Lee, J. Trojanowski, M. Grossman (2013)
White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degenerationJournal of Neurology, Neurosurgery & Psychiatry, 84
P. Lei, S. Ayton, D. Finkelstein, L. Spoerri, G. Ciccotosto, David Wright, Bruce Wong, P. Adlard, R. Cherny, Linh Lam, Blaine Roberts, I. Volitakis, G. Egan, C. Mclean, R. Cappai, J. Duce, A. Bush (2012)
Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron exportNature Medicine, 18
C. Lasagna-Reeves, D. Castillo-Carranza, U. Sengupta, M. Guerrero-Munoz, T. Kiritoshi, V. Neugebauer, G. Jackson, R. Kayed (2012)
Alzheimer brain-derived tau oligomers propagate pathology from endogenous tauScientific Reports, 2
C. McMillan, C. Boyd, R. Gross, Jessica Weinstein, Kim Firn, J. Toledo, K. Rascovsky, L. Shaw, D. Wolk, D. Irwin, Eddie Lee, J. Trojanowski, M. Grossman (2016)
Multimodal imaging evidence of pathology-mediated disease distribution in corticobasal syndromeNeurology, 87
Qiu-lan Ma, X. Zuo, Fusheng Yang, O. Ubeda, Dana Gant, Mher Alaverdyan, Nicolae Kiosea, Sean Nazari, Ping-ping Chen, F. Nothias, P. Chan, E. Teng, S. Frautschy, G. Cole (2014)
Loss of MAP Function Leads to Hippocampal Synapse Loss and Deficits in the Morris Water Maze with AgingThe Journal of Neuroscience, 34
K. Articus (2012)
Caring for the caregiver: Benefits from a different dosage formAlzheimer's & Dementia, 8
Kevin Morris, John Rossi (2006)
Lentiviral-mediated delivery of siRNAs for antiviral therapyGene Therapy, 13
L. Massey, C. Micallef, D. Paviour, S. O'sullivan, H. Ling, David Williams, C. Kallis, J. Holton, T. Révész, D. Burn, T. Yousry, A. Lees, Nick Fox, H. Jäger (2012)
Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophyMovement Disorders, 27
L. Leclair-Visonneau, T. Rouaud, B. Debilly, F. Durif, J. Houeto, A. Kreisler, L. Defebvre, E. Lamy, C. Volteau, J. Nguyen, Séverine Dily, P. Damier, C. Boutoleau-Bretonnière, P. Lejeune, P. Derkinderen (2016)
Randomized placebo-controlled trial of sodium valproate in progressive supranuclear palsyClinical Neurology and Neurosurgery, 146
F. Clavaguera, H. Akatsu, G. Fraser, R. Crowther, S. Frank, J. Hench, A. Probst, D. Winkler, Julia Reichwald, M. Staufenbiel, B. Ghetti, M. Goedert, M. Tolnay (2013)
Brain homogenates from human tauopathies induce tau inclusions in mouse brainProceedings of the National Academy of Sciences, 110
D. Irwin, C. McMillan, J. Toledo, S. Arnold, L. Shaw, Li-San Wang, V. Deerlin, V. Lee, J. Trojanowski, M. Grossman (2012)
Comparison of cerebrospinal fluid levels of tau and Aβ 1-42 in Alzheimer disease and frontotemporal degeneration using 2 analytical platforms.Archives of neurology, 69 8
Emre Yaksi, Rachel Wilson (2010)
Electrical Coupling between Olfactory GlomeruliNeuron, 67
A. Hughes, Y. Ben-Shlomo, S. Daniel, A. Lees (1992)
What features improve the accuracy of clinical diagnosis in Parkinson's diseaseNeurology, 42
David Williams, J. Holton, C. Strand, A. Pittman, R. Silva, A. Lees, T. Révész (2007)
Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.Brain : a journal of neurology, 130 Pt 6
R. Sud, Evan Geller, G. Schellenberg (2014)
Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy for TauopathiesMolecular Therapy. Nucleic Acids, 3
I. Magen, Regina Ostritsky, F. Richter, Chunni Zhu, S. Fleming, Vincent Lemesre, Alistair Stewart, Bruce Morimoto, I. Gozes, M. Chesselet (2014)
Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synucleinPharmacology Research & Perspectives, 2
M. Fodero-Tavoletti, N. Okamura, S. Furumoto, R. Mulligan, Andrea Connor, C. Mclean, D. Cao, A. Rigopoulos, G. Cartwright, G. O'Keefe, S. Gong, P. Adlard, K. Barnham, C. Rowe, C. Masters, Y. Kudo, R. Cappai, K. Yanai, V. Villemagne (2011)
18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease.Brain : a journal of neurology, 134 Pt 4
W. Noble, E. Planel, C. Zehr, Vicki Olm, J. Meyerson, Farhana Suleman, Kate Gaynor, Lili Wang, J. Lafrancois, Boris Feinstein, Mark Burns, P. Krishnamurthy, Y. Wen, R. Bhat, Jada Lewis, Dennis Dickson, K. Duff (2005)
Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo.Proceedings of the National Academy of Sciences of the United States of America, 102 19
B. Borroni, A. Benussi, S. Archetti, D. Galimberti, L. Parnetti, B. Nacmias, S. Sorbi, E. Scarpini, A. Padovani (2015)
Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementiaAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 16
L. Collin, B. Bohrmann, U. Göpfert, K. Oroszlan-Szovik, L. Ozmen, F. Grüninger (2014)
Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer's disease.Brain : a journal of neurology, 137 Pt 10
T. Montine, C. Phelps, T. Beach, E. Bigio, N. Cairns, D. Dickson, C. Duyckaerts, M. Frosch, E. Masliah, S. Mirra, P. Nelson, J. Schneider, D. Thal, J. Trojanowski, H. Vinters, B. Hyman (2011)
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approachActa Neuropathologica, 123
K. Walls, Rahasson Ager, V. Vasilevko, David Cheng, Rodrigo Medeiros, F. LaFerla (2014)
p-Tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD miceNeuroscience Letters, 575
Jing Guo, V. Lee (2014)
Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseasesNature Medicine, 20
N. Kouri, O. Ross, B. Dombroski, C. Younkin, D. Serie, A. Soto-Ortolaza, M. Baker, N. Finch, Hyejin Yoon, Jungsu Kim, S. Fujioka, C. Mclean, B. Ghetti, S. Spina, L. Cantwell, M. Farlow, J. Grafman, E. Huey, Mi Han, Sherry Beecher, Evan Geller, H. Kretzschmar, S. Roeber, M. Gearing, J. Juncos, J. Vonsattel, V. Deerlin, M. Grossman, H. Hurtig, R. Gross, S. Arnold, J. Trojanowski, V. Lee, G. Wenning, C. White, G. Höglinger, U. Müller, B. Devlin, L. Golbe, J. Crook, J. Parisi, B. Boeve, K. Josephs, Z. Wszolek, R. Uitti, N. Graff-Radford, I. Litvan, S. Younkin, Li-San Wang, N. Ertekin-Taner, R. Rademakers, Hakon Hakonarsen, G. Schellenberg, D. Dickson (2015)
Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsyNature Communications, 6
Y. Yoshiyama, M. Higuchi, Bin Zhang, Shu-ming Huang, N. Iwata, T. Saido, J. Maeda, T. Suhara, J. Trojanowski, V. Lee (2007)
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse ModelNeuron, 54
F. Clavaguera, T. Bolmont, R. Crowther, D. Abramowski, S. Frank, A. Probst, G. Fraser, A. Stalder, M. Beibel, M. Staufenbiel, M. Jucker, M. Goedert, M. Tolnay (2009)
Transmission and spreading of tauopathy in transgenic mouse brainNature cell biology, 11
Richard Smith, Richard Smith, T. Miller, K. Yamanaka, B. Monia, T. Condon, G. Hung, C. Lobsiger, Chris Ward, Melissa McAlonis-Downes, Hongbing Wei, E. Wancewicz, C. Bennett, D. Cleveland (2006)
Antisense oligonucleotide therapy for neurodegenerative disease.The Journal of clinical investigation, 116 8
D. Barten, P. Fanara, C. Andorfer, N. Hoque, P. Wong, K. Husted, G. Cadelina, L. Decarr, Ling Yang, Victoria Liu, C. Fessler, Joan Protassio, Timothy Riff, Holly Turner, C. Janus, S. Sankaranarayanan, C. Polson, J. Meredith, Gemma Gray, A. Hanna, R. Olson, Soong-Hoon Kim, G. Vite, F. Lee, C. Albright (2012)
Hyperdynamic Microtubules, Cognitive Deficits, and Pathology Are Improved in Tau Transgenic Mice with Low Doses of the Microtubule-Stabilizing Agent BMS-241027The Journal of Neuroscience, 32
H. Nakashima, T. Ishihara, Pilar Suguimoto, O. Yokota, E. Oshima, Akihide Kugo, S. Terada, T. Hamamura, J. Trojanowski, V. Lee, S. Kuroda (2005)
Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathiesActa Neuropathologica, 110
M. Armstrong, I. Litvan, A. Lang, T. Bak, K. Bhatia, B. Borroni, A. Boxer, D. Dickson, M. Grossman, M. Hallett, K. Josephs, A. Kertesz, Suzee Lee, B. Miller, S. Reich, D. Riley, E. Tolosa, A. Tröster, M. Vidailhet, W. Weiner (2013)
Criteria for the diagnosis of corticobasal degenerationNeurology, 80
E. Huey, K. Putnam, J. Grafman (2006)
A systematic review of neurotransmitter deficits and treatments in frontotemporal dementiaNeurology, 66
V. Lepore, G. Defazio, D. Acquistapace, C. Melpignano, L. Pomés, P. Lamberti, P. Livrea, E. Ferrari (1995)
Botulinum a toxin for the so‐called apraxia of lid openingMovement Disorders, 10
E. Saijo, B. Ghetti, G. Zanusso, A. Oblak, J. Furman, M. Diamond, Allison Kraus, B. Caughey (2017)
Ultrasensitive and selective detection of 3-repeat tau seeding activity in Pick disease brain and cerebrospinal fluidActa Neuropathologica, 133
Sarah DeVos, T. Miller (2013)
Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous SystemJournal of Visualized Experiments : JoVE
L. Möller, J. Kassubek, M. Südmeyer, R. Hilker, E. Hattingen, K. Egger, F. Amtage, E. Pinkhardt, G. Respondek, M. Stamelou, F. Moeller, A. Schnitzler, W. Oertel, S. Knake, H. Huppertz, G. Höglinger (2017)
Manual MRI morphometry in Parkinsonian syndromesMovement Disorders, 32
E. Matsuo, R. Shin, M. Billingsley, Andre deVoorde, Michael O'Connor, J. Trojanowski, V. Lee (1994)
Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tauNeuron, 13
M. Selenica, H. Davtyan, S. Housley, Laura Blair, Anne Gillies, B. Nordhues, Bo Zhang, Joseph Liu, J. Gestwicki, Daniel Lee, M. Gordon, D. Morgan, C. Dickey (2014)
Epitope analysis following active immunization with tau proteins reveals immunogens implicated in tau pathogenesisJournal of Neuroinflammation, 11
V. Lowe, G. Curran, Ping Fang, Amanda Liesinger, K. Josephs, J. Parisi, K. Kantarci, B. Boeve, M. Pandey, T. Bruinsma, D. Knopman, David Jones, L. Petrucelli, C. Cook, N. Graff-Radford, D. Dickson, R. Petersen, C. Jack, M. Murray (2016)
An autoradiographic evaluation of AV-1451 Tau PET in dementiaActa Neuropathologica Communications, 4
Sarah DeVos, T. Miller (2013)
Antisense Oligonucleotides: Treating Neurodegeneration at the Level of RNANeurotherapeutics, 10
D. Dickson, N. Kouri, M. Murray, K. Josephs (2011)
Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau)Journal of Molecular Neuroscience, 45
Yi Yin, Liu Cao, Hongfei Ge, W. Duanmu, Liang Tan, Jichao Yuan, Chen Tunan, Fei Li, Rong Hu, F. Gao, H. Feng (2017)
L-Borneol induces transient opening of the blood–brain barrier and enhances the therapeutic effect of cisplatinNeuroReport, 28
L. Buée, T. Bussiere, V. Buée-Scherrer, A. Delacourte, P. Hof (2000)
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work.Brain Research Reviews, 33
T. Igawa, H. Tsunoda, T. Kuramochi, Zenjiro Sampei, Shinya Ishii, K. Hattori (2011)
Engineering the variable region of therapeutic IgG antibodiesmAbs, 3
D. Irwin, N. Cairns, M. Grossman, C. McMillan, Eddie Lee, V. Deerlin, V. Lee, J. Trojanowski (2015)
Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicineActa Neuropathologica, 129
R. Grondin, M. Kaytor, Y. Ai, P. Nelson, D. Thakker, J. Heisel, Marcy Weatherspoon, Janelle Blum, E. Burright, Zhiming Zhang, W. Kaemmerer (2012)
Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatumBrain, 135
Andrew Wang, Elizabeth Jensen, Jessica Rexach, H. Vinters, L. Hsieh‐Wilson (2016)
Loss of O-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegenerationProceedings of the National Academy of Sciences, 113
G. Höglinger, N. Melhem, D. Dickson, P. Sleiman, Li-San Wang, L. Klei, R. Rademakers, R. Silva, I. Litvan, D. Riley, J. Swieten, P. Heutink, Z. Wszolek, R. Uitti, J. Vandrovcova, H. Hurtig, R. Gross, W. Maetzler, S. Goldwurm, E. Tolosa, B. Borroni, P. Pástor, P. Pástor, L. Cantwell, Mi-Ryung Han, Allissa Dillman, M. Brug, J. Gibbs, J. Gibbs, M. Cookson, D. Hernandez, D. Hernandez, A. Singleton, M. Farrer, Chang-En Yu, L. Golbe, T. Révész, J. Hardy, A. Lees, B. Devlin, H. Hakonarson, U. Müller, G. Schellenberg, R. Albin, E. Alonso, E. Alonso, A. Antonini, M. Apfelbacher, S. Arnold, J. Avila, T. Beach, Sherry Beecher, D. Berg, T. Bird, N. Bogdanovic, A. Boon, Y. Bordelon, A. Brice, A. Brice, A. Brice, H. Budka, M. Canesi, W. Chiu, R. Cilia, C. Colosimo, P. Deyn, J. Yébenes, L. Kaat, R. Duara, A. Durr, A. Durr, A. Durr, S. Engelborghs, G. Fabbrini, N. Finch, Robyn Flook, M. Frosch, C. Gaig, Douglas Galasko, T. Gasser, M. Gearing, Evan Geller, B. Ghetti, N. Graff-Radford, M. Grossman, D. Hall, L. Hazrati, M. Höllerhage, J. Jankovic, J. Juncos, A. Karydas, H. Kretzschmar, I. Leber, I. Leber, I. Leber, V. Lee, A. Lieberman, K. Lyons, C. Mariani, E. Masliah, L. Massey, Catriona McLean, N. Meucci, B. Miller, B. Mollenhauer, J. Möller, H. Morris, Christopher Morris, S. O'sullivan, W. Oertel, D. Ottaviani, A. Padovani, R. Pahwa, G. Pezzoli, S. Pickering-Brown, W. Poewe, A. Rábano, A. Rajput, S. Reich, G. Respondek, S. Roeber, J. Rohrer, O. Ross, M. Rossor, G. Sacilotto, W. Seeley, K. Seppi, L. Silveira-Moriyama, S. Spina, K. Srulijes, P. George-Hyslop, P. George-Hyslop, M. Stamelou, D. Standaert, S. Tesei, W. Tourtellotte, C. Trenkwalder, C. Troakes, J. Trojanowski, J. Troncoso, V. Deerlin, J. Vonsattel, G. Wenning, C. White, P. Winter, C. Zarow, A. Zecchinelli (2011)
Identification of common variants influencing risk of the tauopathy Progressive Supranuclear PalsyNature genetics, 43
M. Forman, J. Trojanowski, V. Lee, M. Esiri (2004)
Hereditary tauopathies and idiopathic frontotemporal dementias
S. Alexander, T. Rittman, J. Xuereb, T. Bak, J. Hodges, J. Rowe (2016)
Explorer Validation of the new consensus criteria for the diagnosis of corticobasal degeneration
Maria Gomes, Jes Dreier, J. Brewer, S. Martins, M. Brandl, B. Sarmento (2016)
A new approach for a blood-brain barrier model based on phospholipid vesicles: Membrane development and siRNA-loaded nanoparticles permeabilityJournal of Membrane Science, 503
D. Irwin, A. Lleó, S. Xie, C. McMillan, D. Wolk, Eddie Lee, V. Deerlin, L. Shaw, J. Trojanowski, M. Grossman (2017)
Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degenerationAnnals of Neurology, 82
Xiyun Chai, Su Wu, T. Murray, R. Kinley, C. Cella, H. Sims, Nicola Buckner, Jenna Hanmer, P. Davies, M. O'Neill, M. Hutton, M. Citron (2011)
Passive Immunization with Anti-Tau Antibodies in Two Transgenic ModelsThe Journal of Biological Chemistry, 286
A. Xuan, Xue-Bing Pan, Peng Wei, W. Ji, Wenjuan Zhang, Ji-Hong Liu, L. Hong, Wen-Liang Chen, D. Long (2015)
Valproic Acid Alleviates Memory Deficits and Attenuates Amyloid-β Deposition in Transgenic Mouse Model of Alzheimer’s DiseaseMolecular Neurobiology, 51
B. Boeve (2011)
The Multiple Phenotypes of Corticobasal Syndrome and Corticobasal Degeneration: Implications for Further StudyJournal of Molecular Neuroscience, 45
Purpose of Review Tauopathies represent a spectrum of incur- markers will aid in identifying tauopathies earlier and more able and progressive age-associated neurodegenerative dis- accurately which will aid in selection for new clinical trials eases that currently are diagnosed definitively only at autopsy. which focus on a variety of agents including immunotherapy Few clinical diagnoses, such as classic Richardson’ssyn- and gene silencing. drome of progressive supranuclear palsy, are specific for un- . . derlying tauopathy and no clinical syndrome is fully sensitive Keywords Tauopathy Progressive supranuclear palsy . . . to reliably identify all forms of clinically manifest tauopathy. Alzheimer’sdisease Immunotherapy Gene therapy Thus, a major unmet need for the development and implemen- Tau-PET tation of tau-targeted therapies is precise antemortem diagno- sis. This article reviews new and emerging diagnostic thera- pies for tauopathies including novel imaging techniques and Introduction biomarkers and also reviews recent tau therapeutics. Recent Findings Building evidence from animal and cell Tau is a highly soluble microtubule-associated protein which models suggests that prion-like misfolding and propagation modulates stability of axonal cytoskeleton and is encoded by of pathogenic tau proteins between brain cells are central to the MAPT gene on chromosome 17q21.3 consisting of 16 the
Current Neurology and Neuroscience Reports – Springer Journals
Published: Aug 7, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.